IUT

EQS-News: Iute Group CEO Tarmo Sild approved as member of the Energbank Supervisory Board

Retrieved on: 
星期六, 九月 16, 2023
Bank, IUT, National bank, Nature, Moldova, National Bank of Moldova

Iute Group, a leading European personal finance group, with Group CEO Tarmo Sild, appoints another Energbank Supervisory Board member.

Key Points: 
  • Iute Group, a leading European personal finance group, with Group CEO Tarmo Sild, appoints another Energbank Supervisory Board member.
  • Tarmo Sild, CEO of Iute Group: “I am very pleased to join Energbank’s Supervisory Board, as this is another milestone for us in the bank’s transformation.
  • We are working on a seamless integration of Energbank into the Iute Group.
  • Our goal is to unleash the bank’s potential to contribute to the Group’s growth.

EQS-News: Iute Group reports unaudited results for 6M/2023 – Quality over quantity translates into moderate growth

Retrieved on: 
星期二, 八月 22, 2023
Pressure, European Central Bank, Interest, POS, Central bank, EUR, IUT, EBITDA, Acquisition, ATM, FX, Coffee, Environment, Security (finance), Video game, Lithium, Online shopping, Bank, Film industry

Group consolidated balance sheet up 8,1% to 348,5 million EUR and equity up 16,9% to 65,6 million EUR as of 30 June 2023.

Key Points: 
  • Group consolidated balance sheet up 8,1% to 348,5 million EUR and equity up 16,9% to 65,6 million EUR as of 30 June 2023.
  • Iute Group, a leading European personal finance group, reported today unaudited results for 6M/2023.
  • In fact, Iute Group continued its moderate growth in Q2 2023, focusing on quality rather than quantity.
  • Both recent events represent significant milestones in the Iute story as we continue our journey to make money for our investors,” said Tarmo Sild, CEO of Iute Group.

EQS-News: Iute Group EUR 2021/2026 bondholders with great consent to amend terms and conditions – Bondholders’ Meeting secures greater financial flexibility for growth

Retrieved on: 
星期五, 八月 4, 2023
Financial adviser, 2022 Michigan Proposal 3, Proposal 2, 2015 Michigan Proposal 1, Trust, Documentation, Acquisition, ISIN, Growth, Security (finance), IUT

Iute Group, a leading European personal finance group, through its fully owned subsidiary IuteCredit Finance S.à r.l., has received great consent from bondholders to amend the terms and conditions of its EUR 2021/2026 bonds (ISIN: XS2378483494).

Key Points: 
  • Iute Group, a leading European personal finance group, through its fully owned subsidiary IuteCredit Finance S.à r.l., has received great consent from bondholders to amend the terms and conditions of its EUR 2021/2026 bonds (ISIN: XS2378483494).
  • The participants voted with 95% almost unanimously in favor of each of the resolutions, thereby also duly meeting the majority thresholds.
  • Tarmo Sild, Group CEO: “We thank the bondholders for their trust in Iute.
  • Iute grows and develops thanks to joint efforts, in which the people who invest their money in Iute play a major role.

EQS-News: Iute initiates process to amend terms and conditions of EUR 2021/2026 bonds – Invitation to Bondholders’ Meeting on 3 August 2023

Retrieved on: 
星期四, 七月 13, 2023
Condition, Financial adviser, 2018 Michigan Proposal 3, Proposal 2, 2022 Michigan Proposal 1, IUT, EBITDA, Terms and Conditions May Apply, Acquisition, Moldovan, ISIN, Growth, Security (finance)

Iute Group, a leading European personal finance group, through its fully owned subsidiary IuteCredit Finance S.à r.l., has initiated the formal process to amend the terms and conditions of its EUR 2021/2026 bonds (ISIN: XS2378483494).

Key Points: 
  • Iute Group, a leading European personal finance group, through its fully owned subsidiary IuteCredit Finance S.à r.l., has initiated the formal process to amend the terms and conditions of its EUR 2021/2026 bonds (ISIN: XS2378483494).
  • The above resolution proposals constitute a Uniform Resolution Proposal and will therefore only be voted uniformly on as a Uniform Resolution Proposal.
  • The results of the voting will be available on the Group’s website subsequent to the meeting of the bondholders.
  • Holders of EUR 2021/2026 bonds are encouraged to reach out directly to Aalto Capital for more information regarding the process for amending the terms and conditions of the bonds:

EQS-News: Iute places EUR 10 million tap on EUR 2021/2026 bonds in connection with exchange offer for EUR 2019/2023 bonds – Total volume of bonds outstanding EUR 125 million

Retrieved on: 
星期三, 七月 5, 2023
Frankfurt Stock Exchange, EUR, Financial adviser, IUT, General Standard, P.A. Semi, Security (finance), Baltic

Iute Group, a leading European personal finance group, through its fully owned subsidiary IuteCredit Finance S.á r.l., today issued EUR 2021/2026 bonds in the amount of EUR 10 million with an interest rate of 11.0% p.a.

Key Points: 
  • Iute Group, a leading European personal finance group, through its fully owned subsidiary IuteCredit Finance S.á r.l., today issued EUR 2021/2026 bonds in the amount of EUR 10 million with an interest rate of 11.0% p.a.
  • Of this amount, EUR 7.2 million was attributable to holders of the EUR 2019/2023 bond, who exercised the exchange offer at an issue price of 96.5%.
  • EUR 2.8 million of the new EUR 2021/2026 bonds were subscribed by the company's shareholders.
  • The tap issue brings the total volume of Iute Group’s EUR 2021/2026 bonds to EUR 125 million.

New Phase 2 Data Demonstrate Potential Benefit of Nipocalimab for Pregnant Individuals at High Risk of Early-Onset Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

Retrieved on: 
星期一, 六月 26, 2023
EOS, HDFN, Fetus, Umbilical cord, European Medicines Agency, Janssen, Janssen Pharmaceuticals, Patient, Memorial Hermann–Texas Medical Center, Risk, Immunoglobulin G, Disease, Infant, IUT, Neonatal Fc receptor, UNITY, Tissue, Ohio State University, Hydrops, University, Dell Medical School, Gestational age, EMA, SPRING, Diagnosis, FDA, FC, Placenta, HOUSE, Health, Maternal–fetal medicine, Child, Șaeș, Blood, Immune system, Mortality, Johnson & Johnson, Epidural hematoma, Anemia, Infection, Edema, Clinical trial, Fast Track, Mount Sinai Hospital, Regulation of tobacco by the U.S. Food and Drug Administration, Food, Birth control, Dietary supplement

SPRING HOUSE, Pa., June 26, 2023 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced positive results from the proof-of-concept Phase 2 open-label UNITY clinical trial for the treatment of pregnant individuals at high risk of early-onset severe (EOS) hemolytic disease of the fetus and newborn (HDFN).1 A statistically significant (54 percent [n=7/13]) proportion of participants who received nipocalimab achieved the primary endpoint of a live birth at or after gestational age of 32 weeks without intrauterine transfusions (IUTs)1,a compared to the historic reference point of 10 percent, which was derived from published and unpublished data.2-5,b Among the seven participants who achieved the primary endpoint, the median gestational age at delivery was 37 and 1/7 weeks.6 This study demonstrates the potential for nipocalimab to help address the underlying disease mechanism of EOS HDFN.1 If approved, nipocalimab would be the first anti-neonatal Fc receptor (FcRn) treatment and the first approved non-surgical intervention for pregnancies at high risk of HDFN in the U.S.7 These data will be presented for the first time at the Fetal Medicine Foundation World Congress in Valencia, Spain on June 26, 2023.1 Janssen is planning a pivotal Phase 3 trial for nipocalimab in pregnancies at risk for severe HDFN.

Key Points: 
  • "There is a significant unmet need to help address the serious and life-threatening health consequences of HDFN.
  • "These Phase 2 UNITY data in high-risk pregnancies demonstrated the important role that nipocalimab, an FcRn blocking antibody, may play in preventing the transfer of maternal alloantibodies through the placenta, thereby offering a potential treatment option for this devastating disease."
  • A conservative benchmark of 10 percent of patients not requiring an IUT was chosen to account for uncertainties in the accuracy and representation of the underlying data.2
    d.  Dr. Kenneth Moise is a paid consultant for Janssen.
  • He has not been compensated for any media work.

EQS-News: Iute places EUR 40 million tap on EUR 2021/2026 bonds – Strong appetite from existing investors boosted by new subscriptions

Retrieved on: 
星期六, 四月 15, 2023
Regulated market, Pressure, Financial adviser, Frankfurt Stock Exchange, Market, EUR, IUT, Security (finance), Cryptocurrency

IuteCredit Europe (“ICE”), a leading European personal finance group, through its fully owned subsidiary IuteCredit Finance S.á r.l., issued EUR 2021/2026 bonds worth EUR 40 million.

Key Points: 
  • IuteCredit Europe (“ICE”), a leading European personal finance group, through its fully owned subsidiary IuteCredit Finance S.á r.l., issued EUR 2021/2026 bonds worth EUR 40 million.
  • The tap issue brings the total volume of IuteCredit’s EUR 2021/2026 bonds to EUR 115 million.
  • Strong appetite from existing investors to exchange EUR 2019/2023 bonds of more than EUR 23.3 million as part of the ongoing EUR 2021/2026 bonds tap issue was boosted by new subscriptions in the amount of EUR 16.7 million.
  • Tarmo Sild, Head of Iute Group: “The successful bond issue is recognition for our team and our technology.

EQS-News: Iute with strong Appetite from existing investors for EUR 2021/2026 bonds exchange offer – Public Offer for EUR 2021/2026 Bonds continues until 31 March 2023

Retrieved on: 
星期五, 三月 31, 2023
Commission, Commission de Surveillance du Secteur Financier, ISIN, Growth, EUR, CEST, CSSF, Security (finance), IUT

The public offering of the new EUR 2021/2026 bonds is available for subscription by investors through their custodian banks until 31 March 2023.

Key Points: 
  • The public offering of the new EUR 2021/2026 bonds is available for subscription by investors through their custodian banks until 31 March 2023.
  • The new EUR 2021/2026 bonds will be offered for subscription at an issue price which translates to a yield to maturity for public offering bonds is in the range of 12%.
  • The issuing price of the new EUR 2021/2026 bonds is expected to be conclusively determined and announced on 31 March 2023 on the basis of the subscription offers received.
  • Tarmo Sild, Head of Iute Group: “Investors have trusted us and continue to invest in Iute with attractive returns.

EQS-News: Iute Group reports unaudited results for 12M/2022 – On its way to a profitable fintech bank

Retrieved on: 
星期三, 二月 22, 2023
FX, Traction, National bank, Development, Acquisition, EBITDA, EUR, ATM, Senior, Data science, Risk, Growth, Interest, Data management, E-Land Group, National Bank of Moldova, Security (finance), Film industry, Lithium, Airline, Cryptocurrency, Bank, Risk management, Eurobond, IUT

Group consolidated balance sheet up 93,3% to 322,3 million EUR and equity doubled to 56,1 million EUR as of 31 Dec. 2022.

Key Points: 
  • Group consolidated balance sheet up 93,3% to 322,3 million EUR and equity doubled to 56,1 million EUR as of 31 Dec. 2022.
  • Moldovan bank management integrated into Iute, administration by National Bank of Moldova completed.
  • IuteCredit Europe (“ICE”), a leading European personal finance group, reported today unaudited results for 12M/2022.
  • CEO Tarmo Sild and CFO Kristel Kurvits will comment on the unaudited 12M/2022 results by means of a webcast presentation on 22 February 2023, 10.00 CET.

EQS-News: IuteCredit reports unaudited results for 9M/2022 – The Fintech Formula: Capital, technology, data, and human skills in, profit out

Retrieved on: 
星期日, 十一月 27, 2022
Growth, Environment, CPI, EBITDA, MDL, Interest, FX, Risk, ATM, IUT, OPEX, Technology transfer, Investment, Financial technology, Ecosystem, APR, Acquisition, Renewable energy, Security (finance), Film, Online shopping, Cryptocurrency, Bank, Q3, Moldovan, E-Land Group, EUR

IuteCredit reports unaudited results for 9M/2022 The Fintech Formula: Capital, technology, data, and human skills in, profit out

Key Points: 
  • IuteCredit reports unaudited results for 9M/2022 The Fintech Formula: Capital, technology, data, and human skills in, profit out
    The issuer is solely responsible for the content of this announcement.
  • Progress in achieving operational control in Moldovan Energbank with Iute manager appointed board member know-how and technology transfer to start.
  • Increasing use of MyIute app drives wallet revenues, also with e-commerce solutions 391 thousand downloads (31December 2021: 181thousand).
  • Continued investments into New Core IT platform for customer management of integrated loans and wallet service value streams incl.